The EPAD project launches a brand-new website


The European Prevention of Alzheimer's Dementia (EPAD) project is pleased to announce the launch of its new website. It’s more user-friendly, packed with updated information and easier to navigate. The EPAD project was driven by the idea that early, targeted intervention focused on the initial stages of disease would be more effective than efforts to tackle established disease processes. With gratitude to the Innovative Medicines Initiative (IMI) for funding (2015-2020), EPAD was an interdisciplinary research initiative established to overcome the major hurdles hampering drug development for secondary prevention of dementia due to Alzheimer’s disease. 

It also pioneered a novel, flexible approach to clinical trials. Over 2,000 research participants were recruited into the four-year EPAD Longitudinal Cohort Study exploring new ways to better understand the early stages of Alzheimer’s disease and prevent dementia before symptom onset. The data, bio sample and neuroimaging generated from this study are available for researchers studying the brain and neurodegenerative diseases around the world. We invite you to explore the new website to find further information on how to request access.